Summary & Overview
CPT 50391: Therapeutic Instillation into Renal Pelvis or Ureter
CPT code 50391 denotes the instillation of a therapeutic agent—such as an anticarcinogenic or antifungal medication—directly into the renal pelvis and/or ureter via a pre-existing nephrostomy, pyelostomy, or ureterostomy tube. This targeted local therapy is used in select urologic and oncologic contexts to deliver medication to the upper urinary tract and can reduce systemic exposure while concentrating treatment at the disease site. Nationally, the code matters for hospitals, interventional radiology services, and urology practices that manage patients with urinary tract stomas or nephrostomy access.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical purpose and service setting, common billing modifiers and practical billing context, and pointers to related procedural and diagnosis coding where available. The publication summarizes typical sites of service and the procedural intent, clarifies common modifier usage patterns, and highlights areas where payers commonly require documentation to support the medical necessity of local instillation therapies. Data not available in the input will be noted explicitly in relevant sections.
Billing Code Overview
CPT code 50391 describes injection of a therapeutic agent (for example, an anticarcinogenic or antifungal medication) into the renal pelvis and/or ureter through a previously established nephrostomy, pyelostomy, or ureterostomy tube. This procedure is a targeted, local instillation of medication into the upper urinary collecting system.
-
Service type: Therapeutic instillation into renal pelvis and/or ureter via existing ostomy or nephrostomy tube
-
Typical site of service: Procedures are typically performed in inpatient or outpatient hospital procedural areas, interventional radiology suites, or specialized urology clinics where patients have an existing nephrostomy, pyelostomy, or ureterostomy tube
Clinical & Coding Specifications
Clinical Context
A 68-year-old male with a long-standing percutaneous nephrostomy tube placed for management of an infected, obstructed kidney from transitional cell carcinoma returns to interventional radiology/urology for instillation of a chemotherapeutic agent into the renal collecting system. The procedure is performed through the existing nephrostomy tube under sterile conditions. The provider confirms tube patency and correct positioning by aspirating urine and, if indicated, injecting a small amount of contrast under fluoroscopy. After confirming access to the renal pelvis and/or proximal ureter, the provider injects the prescribed therapeutic agent (for example, an anticarcinogenic intrapelvic instillation) slowly through the nephrostomy tube. The patient is monitored for pain, signs of systemic absorption/allergic reaction, bleeding, or extravasation. Typical workflow includes verification of indications and consent, review of prior imaging and recent labs (including coagulation status), analgesia or conscious sedation as required, procedure documentation of the agent, dose, volume, dwell time if applicable, and tube clamping or drainage instructions upon completion. Expected sites of service are interventional radiology suite, ambulatory surgery center, or hospital inpatient setting when the nephrostomy/pyelostomy/ureterostomy tube is already in place and the instillation is performed through that preexisting access.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Normal, standard performance of the service | Use when the procedure is performed as expected without complications or unusual circumstances. |